Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bin Yang, Ana Gomes Dos Santos, Sanyogitta Puri, Annette Bak & Liping Zhou. (2022) The industrial design, translation, and development strategies for long-acting peptide delivery. Expert Opinion on Drug Delivery 19:10, pages 1233-1245.
Read now
Read now
Jametta S Magwood, Akida Lebby, Brian Chen, Sam Kessler, LeAnn Norris & Charles L Bennett. (2013) Emerging drugs for treatment of anemia of chronic kidney disease. Expert Opinion on Emerging Drugs 18:4, pages 421-429.
Read now
Read now
Holger Schmid. (2013)
Peginesatide for the treatment of renal disease-induced anemia. Expert Opinion on Pharmacotherapy 14:7, pages 937-948.
Read now
Read now
Articles from other publishers (26)
Peng Xu, Raymond S. M. Wong, Wojciech Krzyzanski & Xiaoyu Yan. (2022) Dynamics of Erythroferrone Response to Erythropoietin in Rats. Frontiers in Pharmacology 13.
Crossref
Crossref
Kit-Kay Mak, Ola Epemolu & Mallikarjuna Rao Pichika. (2022) The role of DMPK science in improving pharmaceutical research and development efficiency. Drug Discovery Today 27:3, pages 705-729.
Crossref
Crossref
Masoud Karbasian, Hasan Kouchakzadeh, Parvin Najafi Anamaghi & Yahya Sefidbakht. (2019) Design, development and evaluation of PEGylated rhGH with preserving its bioactivity at highest level after modification. International Journal of Pharmaceutics 557, pages 9-17.
Crossref
Crossref
Nupur Gupta & Jay B. Wish. (2018) Erythropoietin mimetic peptides and erythropoietin fusion proteins for treating anemia of chronic kidney disease. Current Opinion in Nephrology and Hypertension 27:5, pages 345-350.
Crossref
Crossref
Michaela Gebauer & Arne Skerra. (2018) Prospects of PASylation® for the design of protein and peptide therapeutics with extended half-life and enhanced action. Bioorganic & Medicinal Chemistry 26:10, pages 2882-2887.
Crossref
Crossref
Yohei Kotsuchibashi. 2018. Materials Nanoarchitectonics. Materials Nanoarchitectonics
277
290
.
Mina El-Kateb & Robert Provenzano. 2018. Management of Anemia. Management of Anemia
113
127
.
Sathish Dyawanapelly, Nishant Kumar Jain, Sindhu KR, Maruthi Prasanna & Akhilesh Vikram Singh. 2017. Handbook of Composites from Renewable Materials. Handbook of Composites from Renewable Materials
483
541
.
Wolfgang Jelkmann. (2017) Watch out for a revival of peginesatide in sports. Drug Testing and Analysis 9:2, pages 157-160.
Crossref
Crossref
Ola Sternebring, Jesper Kammersgaard Christensen & Inga Bjørnsdottir. (2016) Pharmacokinetics, tissue distribution, excretion, and metabolite profiling of PEGylated rFIX (nonacog beta pegol, N9-GP) in rats. European Journal of Pharmaceutical Sciences 92, pages 163-172.
Crossref
Crossref
Yohei Kotsuchibashi, Yasuhiro Nakagawa & Mitsuhiro Ebara. 2016. Biomaterials Nanoarchitectonics. Biomaterials Nanoarchitectonics
7
23
.
Mary Pat Knadler, Bernice B. Ellis, Patricia L. Brown-Augsburger, Anthony T. Murphy, Jennifer A. Martin & Victor J. Wroblewski. (2015) Disposition of Basal Insulin Peglispro Compared with 20-kDa Polyethylene Glycol in Rats Following a Single Intravenous or Subcutaneous Dose. Drug Metabolism and Disposition 43:10, pages 1477-1483.
Crossref
Crossref
Andrew McEwen & Claire Henson. (2015) Quantitative whole-body autoradiography: past, present and future. Bioanalysis 7:5, pages 557-568.
Crossref
Crossref
Andreas Baumann, Dietrich Tuerck, Saileta Prabhu, Leslie Dickmann & Jennifer Sims. (2014) Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?. Drug Discovery Today 19:10, pages 1623-1631.
Crossref
Crossref
Yan Zou, Thomas J. Bateman, Christine Adreani, Xiaolan Shen, Paul K. Cunningham, Bo Wang, Tu Trinh, Amy Christine, Xuening Hong, Christian N. Nunes, Chris V. Johnson, Andy S. Zhang, Steve J. Staskiewicz, Matthew Braun, Sanjeev Kumar & Vijay Bhasker G. Reddy. (2013) Lymphatic Absorption, Metabolism, and Excretion of a Therapeutic Peptide in Dogs and Rats. Drug Metabolism and Disposition 41:12, pages 2206-2214.
Crossref
Crossref
Yutaka Ikeda, Jinya Katamachi, Hiromichi Kawasaki & Yukio Nagasaki. (2013) Novel Protein PEGylation Chemistry via Glutalaldehyde-Functionalized PEG. Bioconjugate Chemistry 24:11, pages 1824-1827.
Crossref
Crossref
Himanshu Naik, Max C. Tsai, Jill Fiedler-Kelly, Ping Qiu & Majid Vakilynejad. (2013) A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis. PLoS ONE 8:6, pages e66422.
Crossref
Crossref
Kathryn W. Woodburn, Kei-Lai Fong, Susan D. Wilson, Steven Sloneker, Paul Strzemienski, Eric Solon, Yuu Moriya & Yoshihiko Tagawa. (2013) Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration. Drug Metabolism and Disposition 41:4, pages 774-784.
Crossref
Crossref
Iain C. Macdougall, Robert Provenzano, Amit Sharma, Bruce S. Spinowitz, Rebecca J. Schmidt, Pablo E. Pergola, Raja I. Zabaneh, Sandra Tong-Starksen, Martha R. Mayo, Hong Tang, Krishna R. Polu, Anne-Marie Duliege & Steven Fishbane. (2013) Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis. New England Journal of Medicine 368:4, pages 320-332.
Crossref
Crossref
Steven Fishbane, Brigitte Schiller, Francesco Locatelli, Adrian C. Covic, Robert Provenzano, Andrzej Wiecek, Nathan W. Levin, Mark Kaplan, Iain C. Macdougall, Carol Francisco, Martha R. Mayo, Krishna R. Polu, Anne-Marie Duliege & Anatole Besarab. (2013) Peginesatide in Patients with Anemia Undergoing Hemodialysis. New England Journal of Medicine 368:4, pages 307-319.
Crossref
Crossref
Joanne Bronson, Amelia Black, T. G. Murali Dhar, Bruce A. Ellsworth & J. Robert Merritt. 2013.
471
546
.
Wolfgang Jelkmann. 2013. Introduction to Biological and Small Molecule Drug Research and Development. Introduction to Biological and Small Molecule Drug Research and Development
307
326
.
Anatole Besarab, Steven N Zeig, Edouard R Martin, Pablo E Pergola, Frederick C Whittier, Raja I Zabaneh, Brigitte Schiller, Martha Mayo, Carol A Francisco, Krishna R Polu & Anne-Marie Duliege. (2012) An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients. BMC Nephrology 13:1.
Crossref
Crossref
Ines Möller, Andreas Thomas, Philippe Delahaut, Hans Geyer, Wilhelm Schänzer & Mario Thevis. (2012) Mass spectrometric detection of peginesatide in human urine in doping control analysis. Journal of Pharmaceutical and Biomedical Analysis 70, pages 512-517.
Crossref
Crossref
Ines Möller, Andreas Thomas, Anke Wingender, Marc Machnik, Wilhelm Schänzer & Mario Thevis. (2012) Detection of Peginesatide in Equine Serum Using Liquid Chromatography-Tandem Mass Spectrometry for Doping Control Purposes. European Journal of Mass Spectrometry 18:4, pages 407-412.
Crossref
Crossref
Ines Möller, Andreas Thomas, Hans Geyer, Wilhelm Schänzer & Mario Thevis. (2012) Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing. Analytical and Bioanalytical Chemistry 403:9, pages 2715-2724.
Crossref
Crossref